2025-04-01 2026-03-31 false Capium Accounts Production 1.1 11864261 2025-04-01 2026-03-31 11864261 bus:AbridgedAccounts 2025-04-01 2026-03-31 11864261 bus:FRS102 2025-04-01 2026-03-31 11864261 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 11864261 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 11864261 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 11864261 2025-04-01 2026-03-31 11864261 2026-03-31 11864261 bus:RegisteredOffice 2025-04-01 2026-03-31 11864261 core:WithinOneYear 2026-03-31 11864261 core:AfterOneYear 2026-03-31 11864261 1 2025-04-01 2026-03-31 11864261 bus:Director1 2025-04-01 2026-03-31 11864261 bus:Director1 2026-03-31 11864261 bus:Director1 2024-04-01 2025-03-31 11864261 2024-04-01 11864261 bus:LeadAgentIfApplicable 2025-04-01 2026-03-31 11864261 2024-04-01 2025-03-31 11864261 2025-03-31 11864261 core:WithinOneYear 2025-03-31 11864261 core:AfterOneYear 2025-03-31 11864261 bus:EntityAccountantsOrAuditors 2024-04-01 2025-03-31 11864261 core:ComputerEquipment 2025-04-01 2026-03-31 11864261 core:ComputerEquipment 2026-03-31 11864261 core:ComputerEquipment 2025-03-31 11864261 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2026-03-31 11864261 core:LeasedAssetsHeldAsLessee core:PlantMachinery 2025-03-31 11864261 core:CostValuation core:Non-currentFinancialInstruments 2026-03-31 11864261 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 11864261 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2026-03-31 11864261 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 11864261 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2026-03-31 11864261 core:Non-currentFinancialInstruments 2026-03-31 11864261 core:Non-currentFinancialInstruments 2025-03-31 11864261 core:RetainedEarningsAccumulatedLosses 2026-03-31 11864261 core:RetainedEarningsAccumulatedLosses 2025-03-31 11864261 dpl:Item1 2025-04-01 11864261 dpl:Item1 2026-03-31 11864261 dpl:Item1 2024-04-01 11864261 dpl:Item1 2025-03-31 iso4217:GBP xbrli:shares xbrli:pure

Registered Number: 11864261
England and Wales
ACE MEDICARE LTD
Abridged Accounts
Period of accounts Start date: 01 April 2025 End date: 31 March 2026

ACE MEDICARE LTD Contents Page For the year ended 31 March 2026
Accountants' Report | 1
Statement of Financial Position | 2
Notes to the Financial Statements | 3

ACE MEDICARE LTD Accountants' Report For the year ended 31 March 2026
Accountant’s report You consider that the company is exempt from an audit for the year ended 31 March 2026 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year. In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us. We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts. Sembeh Associate Limited 31 March 2026 .................................................... Sembeh Associate Limited 350 Bastable Avenue Barking Essex London IG11 0LL 05 June 2026 1

ACE MEDICARE LTD Statement of Financial Position As at 31 March 2026
| Notes | 2026 £ |  | 2025 £
--- | --- | --- | --- | ---
Fixed assets |  |  |
Tangible fixed assets | 3 | 2,500 |  | 3,750
|  | 2,500 |  | 3,750
Current assets |  |  |
Cash at bank and in hand |  | 2,155 |  | 1,265
Creditors: amount falling due within one year |  | (3,523) |  | (1,527)
Net current assets |  | (1,368) |  | (262)
Total assets less current liabilities |  | 1,132 |  | 3,488
Net assets |  | 1,132 |  | 3,488
Capital and reserves |  |  |
Profit and loss account |  | 1,132 |  | 3,488
Shareholders' funds |  | 1,132 |  | 3,488
For the year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. Director's responsibilities: The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies. The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444(2A). The financial statements were approved by the director on 05 June 2026 and were signed by:
------------------------------- Michael EGUZORAKU Director
2

ACE MEDICARE LTD Notes to the Abridged Financial Statements For the year ended 31 March 2026
General Information ACE MEDICARE LTD is a private company, limited by shares, registered in England and Wales, registration number 11864261, registration address . The presentation currency is £ sterling.
1. | Accounting policies Significant accounting policies Statement of compliance These financial statements have been prepared in compliance with FRS 102 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006. Basis of preparation The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies. The financial statements are prepared in sterling which is the functional currency of the company. Going concern basis The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements. Turnover Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts. Dividends Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date. Tangible fixed assets Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
Computer Equipment | 25% Straight Line
2. | Average number of employees Average number of employees during the year was 1 (2025 : 1).
3. | Tangible fixed assets
Cost or valuation | Computer Equipment |  | Total
| £ |  | £
At 01 April 2025 | 5,000 |  | 5,000
Additions | - |  | -
Disposals | - |  | -
At 31 March 2026 | 5,000 |  | 5,000
Depreciation
At 01 April 2025 | 1,250 |  | 1,250
Charge for year | 1,250 |  | 1,250
On disposals | - |  | -
At 31 March 2026 | 2,500 |  | 2,500
Net book values
Closing balance as at 31 March 2026 | 2,500 |  | 2,500
Opening balance as at 01 April 2025 | 3,750 |  | 3,750
3